Cargando…

Artemisinin-Resistant Malaria: Research Challenges, Opportunities, and Public Health Implications

Artemisinin-based combination therapies are the most effective drugs to treat Plasmodium falciparum malaria. Reduced sensitivity to artemisinin monotherapy, coupled with the emergence of parasite resistance to all partner drugs, threaten to place millions of patients at risk of inadequate treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fairhurst, Rick M., Nayyar, Gaurvika M. L., Breman, Joel G., Hallett, Rachel, Vennerstrom, Jonathan L., Duong, Socheat, Ringwald, Pascal, Wellems, Thomas E., Plowe, Christopher V., Dondorp, Arjen M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The American Society of Tropical Medicine and Hygiene 2012
Materias:	Meeting Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3414557/ https://www.ncbi.nlm.nih.gov/pubmed/22855752 http://dx.doi.org/10.4269/ajtmh.2012.12-0025

Ejemplares similares

Severe Malaria Not Responsive to Artemisinin Derivatives in Man Returning from Angola to Vietnam
por: Ringwald, Pascal, et al.
Publicado: (2015)

Establishing research priorities for malaria elimination in the context of the emergency response to artemisinin resistance framework-the Cambodian approach
por: Canavati, Sara E., et al.
Publicado: (2016)

Effect of High-Dose or Split-Dose Artesunate on Parasite Clearance in Artemisinin-Resistant Falciparum Malaria
por: Das, Debashish, et al.
Publicado: (2013)

The Global Pandemic of Falsified Medicines: Laboratory and Field Innovations and Policy Perspectives
por: Nayyar, Gaurvika M. L., et al.
Publicado: (2015)

Optimising Strategies for Plasmodium falciparum Malaria Elimination in Cambodia: Primaquine, Mass Drug Administration and Artemisinin Resistance
por: Maude, Richard J., et al.
Publicado: (2012)

Optimal sampling designs for accurate estimation of parasite clearance in the context of artemisinin resistance
por: Flegg, Jennifer A, et al.
Publicado: (2012)

Laboratory Detection of Artemisinin-Resistant Plasmodium falciparum
por: Chotivanich, Kesinee, et al.
Publicado: (2014)

Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination
por: Dhorda, Mehul, et al.
Publicado: (2021)

An outbreak of artemisinin resistant falciparum malaria in Eastern Thailand
por: Imwong, Mallika, et al.
Publicado: (2015)

Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives
por: Flegg, Jennifer A, et al.
Publicado: (2013)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?
por: van der Pluijm, Rob W, et al.
Publicado: (2022)

Exploring the feasibility of introducing triple artemisinin-based combination therapy in the malaria treatment policy in Vietnam
por: Cao, Van Anh Thi, et al.
Publicado: (2023)

Defining the In Vivo Phenotype of Artemisinin-Resistant Falciparum Malaria: A Modelling Approach
por: White, Lisa J., et al.
Publicado: (2015)

No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border
por: Huang, Fang, et al.
Publicado: (2020)

Oxidative stress and protein damage responses mediate artemisinin resistance in malaria parasites
por: Rocamora, Frances, et al.
Publicado: (2018)

Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine
por: Song, Jianping, et al.
Publicado: (2010)

Access to artemisinin combination therapy for malaria in remote areas of Cambodia
por: Yeung, Shunmay, et al.
Publicado: (2008)

The Cambodia Research Consortium: expediting research for malaria elimination with the emergency response to artemisinin resistance framework
por: Canavati, Sara E., et al.
Publicado: (2016)

Artemisinin Resistance and Stage Dependency of Parasite Clearance in Falciparum Malaria
por: Intharabut, Benjamas, et al.
Publicado: (2019)

The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia
por: Maude, Richard J, et al.
Publicado: (2009)

A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria
por: Mbengue, Alassane, et al.
Publicado: (2015)

Artemisinin resistance in Plasmodium falciparum is associated with an altered temporal pattern of transcription
por: Mok, Sachel, et al.
Publicado: (2011)

Deploying triple artemisinin-based combination therapy (TACT) for malaria treatment in Africa: ethical and practical considerations
por: Tindana, Paulina, et al.
Publicado: (2021)

The origins of malaria artemisinin resistance defined by a genetic and transcriptomic background
por: Zhu, Lei, et al.
Publicado: (2018)

X-Linked G6PD Deficiency Protects Hemizygous Males but Not Heterozygous Females against Severe Malaria
por: Guindo, Aldiouma, et al.
Publicado: (2007)

The role of mathematical modelling in guiding the science and economics of malaria elimination
por: Maude, Richard J., et al.
Publicado: (2010)

Cost of increasing access to artemisinin combination therapy: the Cambodian experience
por: Yeung, Shunmay, et al.
Publicado: (2008)

Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia
por: Miotto, Olivo, et al.
Publicado: (2013)

Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples
por: Venkatesan, Meera, et al.
Publicado: (2012)

Artemisinin resistance without pfkelch13 mutations in Plasmodium falciparum isolates from Cambodia
por: Mukherjee, Angana, et al.
Publicado: (2017)

Responding to the Pandemic of Falsified Medicines
por: Nayyar, Gaurvika M. L., et al.
Publicado: (2015)

Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study
por: Phyo, Aung Pyae, et al.
Publicado: (2012)

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)

Past and new challenges for malaria control and elimination: the role of operational research for innovation in designing interventions
por: Guyant, Philippe, et al.
Publicado: (2015)

Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders’ perspectives in Burkina Faso and Nigeria
por: Tindana, Paulina, et al.
Publicado: (2022)

Expert perspectives on the introduction of Triple Artemisinin-based Combination Therapies (TACTs) in Southeast Asia: a Delphi study
por: de Haan, Freek, et al.
Publicado: (2022)

Artesunate Dose Escalation for the Treatment of Uncomplicated Malaria in a Region of Reported Artemisinin Resistance: A Randomized Clinical Trial
por: Bethell, Delia, et al.
Publicado: (2011)

Editorial Commentary: Single-Dose Primaquine as Gametocytocidal Treatment in Patients With Uncomplicated Falciparum Malaria
por: Dondorp, Arjen M.
Publicado: (2013)

Randomized trials of artemisinin-piperaquine, dihydroartemisinin-piperaquine phosphate and artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria in Cambodia-Thailand border area
por: Song , Jianping, et al.
Publicado: (2011)

Therapeutic efficacy trial of artemisinin-based combination therapy for the treatment of uncomplicated malaria and investigation of mutations in k13 propeller domain in Togo, 2012–2013
por: Dorkenoo, Améyo M., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1ltm6tcg9fa84k6ddslm9orgf7